In the current issue:
-
Current Recommendations for the Prevention and Treatment of Venous Thromboembolism in Cancer Patients
Halámková Jana et al. -
Coffee in Cancer Chemoprevention
Neuwirthová Jana et al. -
Stereotactic Body Radiotherapy of Prostate Cancer – Effectiveness and Toxicity
Skácelíková Eva et al.
Reviews
Klin Onkol 2017; 30(2): 93-99.
DOI: 10.14735/amko201793.
Keywords: Hodgkin lymphoma – chemotherapy – cognitive impairment – risk factors
Authors: Fayette Dan, Gaherová Ľubica, Kozák Tomáš, Marková Jana, Móciková Heidi, Horáček Jan2017-04-15:Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma – Pathophysiology and Risk Factors
Keywords: Hodgkin lymphoma – chemotherapy – cognitive impairment – risk factors
Authors: Fayette Dan, Gaherová Ľubica, Kozák Tomáš, Marková Jana, Móciková Heidi, Horáček Jan2017-04-15:Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma – Pathophysiology and Risk Factors
Klin Onkol 2017; 30(2): 100-105.
DOI: 10.14735/amko2017100.
Keywords: venous thromboembolism – cancer – central venous catheter thrombosis – guidelines
Authors: Halámková Jana, Penka Miroslav2017-04-15:Current Recommendations for the Prevention and Treatment of Venous Thromboembolism in Cancer Patients
Keywords: venous thromboembolism – cancer – central venous catheter thrombosis – guidelines
Authors: Halámková Jana, Penka Miroslav2017-04-15:Current Recommendations for the Prevention and Treatment of Venous Thromboembolism in Cancer Patients
Klin Onkol 2017; 30(2): 106-114.
DOI: 10.14735/amko2017106.
Keywords: coffee – chemoprevention – antioxidative enzyme – detoxification enzyme – anti-inflammatory effect
Authors: Neuwirthová Jana, Gál Břetislav, Smilek Pavel, Urbánková Pavla2017-04-15:Coffee in Cancer Chemoprevention
Keywords: coffee – chemoprevention – antioxidative enzyme – detoxification enzyme – anti-inflammatory effect
Authors: Neuwirthová Jana, Gál Břetislav, Smilek Pavel, Urbánková Pavla2017-04-15:Coffee in Cancer Chemoprevention
Original articles
Klin Onkol 2017; 30(2): 115-120.
DOI: 10.14735/amko2017115.
Keywords: prostate cancer – incidence – mortality – prevalence – clinical stages
Authors: Ondrušová Martina, Ondruš Dalibor2017-04-15:Trends in Prostate Cancer Epidemiology in Slovakia – an International Comparison
Keywords: prostate cancer – incidence – mortality – prevalence – clinical stages
Authors: Ondrušová Martina, Ondruš Dalibor2017-04-15:Trends in Prostate Cancer Epidemiology in Slovakia – an International Comparison
Klin Onkol 2017; 30(2): 121-127.
DOI: 10.14735/amko2017121.
Keywords: prostate cancer – stereotactic body radiotherapy – quality of life
Authors: Skácelíková Eva, Feltl David, Cvek Jakub, Jelenová Táňa, Knybel Lukáš, Tomášková Hana2017-04-15:Stereotactic Body Radiotherapy of Prostate Cancer – Effectiveness and Toxicity
Keywords: prostate cancer – stereotactic body radiotherapy – quality of life
Authors: Skácelíková Eva, Feltl David, Cvek Jakub, Jelenová Táňa, Knybel Lukáš, Tomášková Hana2017-04-15:Stereotactic Body Radiotherapy of Prostate Cancer – Effectiveness and Toxicity
Case report
Klin Onkol 2017; 30(2): 128-130.
DOI: 10.14735/amko2017128.
Keywords: anemia – autoimmune event – anti-CTLA-4
Authors: Ramos Bruno, Gastal Gustavo, Rovere Rodrigo Kraft2017-04-15:An Autoimmune Haemolytic Anaemia Secondary to Ipilimumab Treatment
Keywords: anemia – autoimmune event – anti-CTLA-4
Authors: Ramos Bruno, Gastal Gustavo, Rovere Rodrigo Kraft2017-04-15:An Autoimmune Haemolytic Anaemia Secondary to Ipilimumab Treatment
Klin Onkol 2017; 30(2): 131-135.
DOI: 10.14735/amko2017131.
Keywords: non-small cell lung cancer – squamous cell carcinoma – erlotinib – treatment – tyrosine kinase inhibitor
Authors: Bratová Monika , Brat Kristián, Tomíšková Marcela, Robešová Blanka, Skřičková Jana2017-04-15:Effect of Erlotinib in 2nd and 3rd Line Anticancer Treatment in Patients with Squamous Cell Lung Cancer – Case Series
Keywords: non-small cell lung cancer – squamous cell carcinoma – erlotinib – treatment – tyrosine kinase inhibitor
Authors: Bratová Monika , Brat Kristián, Tomíšková Marcela, Robešová Blanka, Skřičková Jana2017-04-15:Effect of Erlotinib in 2nd and 3rd Line Anticancer Treatment in Patients with Squamous Cell Lung Cancer – Case Series
